Article Text

Download PDFPDF
Prescribing for pregnancy: inflammatory rheumatic disease
  1. Samantha Steele,
  2. Iona Thorne
  1. Department of Obstetric Medicine, Chelsea and Westminster NHS Foundation Trust, West Middlesex University Hospital, Isleworth, UK
  1. Correspondence to Samantha Steele, Obstetric Medicine Service, Chelsea and Westminster NHS Foundation Trust, West Middlesex University Hospital, Isleworth, London, UK; samantha.steele6{at}


Inflammatory rheumatic disease during pregnancy requires careful management. Key factors for successful pregnancy outcome are disease remission at the time of conception and optimal disease control during pregnancy. This article forms part of a series on prescribing for pregnancy and discusses the impact of inflammatory arthritis on pregnancy and the influence pregnancy may have on inflammatory arthritis. It highlights the importance of prepregnancy care and collaborative working between obstetric and rheumatology specialties as well as focusing on prescribing before, during and after pregnancy.

  • Pregnancy
  • Joint Diseases
  • Immune System Diseases
  • Contraception
  • Breast feeding

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.